Pharsight

Shandong Luye patents expiration

1. Rykindo patents expiration

RYKINDO's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10406161 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(8 years from now)

US10098882 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(8 years from now)

US9532991 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(8 years from now)

US9446135 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(8 years from now)

US11110094 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(8 years from now)

Drugs and Companies using RISPERIDONE ingredient

Market Authorisation Date: 13 January, 2023

Treatment: Treatment of schizophrenia in adults

Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage

RYKINDO family patents

Family Patents